22 ． Leprosy Research Center( Department of Mycobacteriology)

protein. J. Immunol., 183:6561-6568.
8)

Hatta, M., M. Makino, Ratnawati, Mashudi, Yadi, M.
Sabir, N. Tandirogang, L. M. Rusyati, M. Kai, Y.

1)Makino, M., Y. Maeda, M. Kai, T. Tamura, and T. Mukai.

Fukutomi, Y. Miyamoto, T. Mukai, and Y. Maeda. 2009.

2009.

byDetection of serum antibodies to M. leprae Major

macrophages infected with recombinant BCG thatMembrane Protein-II in leprosy patients from Indonesia.

secretes major membrane protein-II of Mycobacterium

Lepr. Rev. 80: 402-409.

GM-CSF-mediatedT-cellactivation

leprae. FEMS Immunol. Med. Microbiol., 55: 39-46.
2)

3)

4)

9)

Fukutomi, Y., Y. Maeda, M. Matsuoka, and M. Makino.

Akira S, Sakaue-Sawano A, Miyawaki A, Yamanaka Y,

2009.

of

Hirano H, Suzuki K, Okuda K. 2009. A signaling

Mycobacterium leprae in macrophages. Jpn. J. leprosy,

polypeptide derived from an innate immune adaptor

78: 7-16.

molecule can be harnessed as a new class of vaccine

Maeda, Y., T. Tamura, M. Matsuoka, and M. Makino.

adjuvant. J. Immunol 182:1593-601.

Temperaturedependency

forsurvival

2009. Inhibition of the multiplication of Mycobacterium10) Akama T, Suzuki K, Tanigawa K, Kawashima A, Wu H,

leprae by vaccination with a recombinant M. bovis BCG

Nakata N, Osana Y, Sakakibara Y and Ishii N. 2009.

strain that secretes major membrane protein-II in mice.

Whole genome tiling array analysis of Mycobacterium

Clin. Vaccine Immunol. 16: 1399-1404.

leprae RNA reveals high expression of pseudogenes andMonot M, Honoré N, Garnier T, Zidane N, Sherafi D,

non-coding regions. J. Bacteriol 191:3321-3327.

Paniz-Mondolfi A, Matsuoka M, Taylor GM, Donoghue11) Bang PD, Suzuki K, Phuong LT, Chu TM, Ishii N andHD, Bouwman A, Mays S, Watson C, Lockwood D,Khang TH. 2009. Evaluation of PCR-based detection ofKhamesipour A, Dowlati Y, Jianping S, Rea TH,

Mycobacterium leprae for the diagnosis of leprosy. J

Vera-Cabrera L, Stefani MM, Banu S, Macdonald M,Dermatol 36:269-276.

Sapkota BR, Spencer JS, Thomas J, Harshman K, Singh P,

12) Tanigawa K, Suzuki K, Kimura H, Takeshita F, Wu H,Busso P, Gattiker A, Rougemont J, Brennan PJ, Cole ST.

Akama T, Kawashima A, and Ishii N. 2009. Tryptophan

2009.

aspartate-containing coat protein (CORO1A) suppresses

analysis

Comparativeofgenomic

andMycobacterium

phylogeographicleprae.

NatGenet.

Toll-like receptor signalling in Mycobacterium leprae

41:1282-1289.
5)

6)

7)

Kobiyama K, Takeshita F, Ishii KJ, Koyama S, Aoshi T,infection. Clin Exp Immunol 156:495-501.

Matsuoka M, Gonzalez AV, Estrada I, Carreño-Martinez13) Nakamura K, Akama T, Pham DB, Sekimura S, Tanigawa

C, Fafutis-Morris M. 2009. Various genotypes ofK, Wu H, Kawashima A, Hayashi M, Suzuki K and Ishii

Mycobacterium leprae from Mexico reveal distinct

N. 2009. Detection of RNA expression from pseudogenes

geographic distribution. Lepr Rev. 80:322-326.

and noncoding genomic regions of Mycobacterium leprae.

Gillis T, Vissa V, Matsuoka M, Young S, Richardus JH,Microb Pathog 47:183-187.

Truman R, Hall B, Brennan P; Ideal Consortium Partners.

14) Koba, A. N. Ishii, S. Mori, PE. Fine. 2009. The decline of2009. Characterisation of short tandem repeats forleprosy in Japan: patterns and trends 1964-2008. Lepr Rev.

genotyping Mycobacterium leprae. Lepr Rev. 80:250-60.

80:432-40.

Mukai, T., Y. Maeda, T. Tamura, M. Matsuoka, Y.
Tsukamoto,cross-primingandofM.

Makino.

naïveCD8+

2009.

InductionofT lymphocytesby15) Matsuoka M. 2010.
Infect Dis. 63:1-7.

recombinant Bacillus Calmette-Guérin that secretes heatshock protein 70-major membrane protein-II fusion
1

Drug resistance in leprosy. Jpn J